These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
379 related articles for article (PubMed ID: 37466068)
21. Citalopram, QTc interval prolongation, and torsade de pointes. How should we apply the recent FDA ruling? Vieweg WV; Hasnain M; Howland RH; Hettema JM; Kogut C; Wood MA; Pandurangi AK Am J Med; 2012 Sep; 125(9):859-68. PubMed ID: 22748401 [TBL] [Abstract][Full Text] [Related]
22. QTc interval prolongation associated with citalopram overdose: a case report and literature review. Catalano G; Catalano MC; Epstein MA; Tsambiras PE Clin Neuropharmacol; 2001; 24(3):158-62. PubMed ID: 11391127 [TBL] [Abstract][Full Text] [Related]
23. Prolonged QTc interval and torsades de pointes induced by citalopram. Deshmukh A; Ulveling K; Alla V; Abuissa H; Airey K Tex Heart Inst J; 2012; 39(1):68-70. PubMed ID: 22412232 [TBL] [Abstract][Full Text] [Related]
24. A question about the potential cardiac toxicity of escitalopram. Howland RH J Psychosoc Nurs Ment Health Serv; 2012 Apr; 50(4):17-20. PubMed ID: 22421011 [TBL] [Abstract][Full Text] [Related]
25. [Citalopram is not safe from the cardiac point of view--SSRI preparations can cause prolonged QTc time]. Odar-Cederlöf I; Hjelmström P; Jersenius I; Andersson M; Rasmanis G; Bergman U Lakartidningen; 2006 Apr 5-11; 103(14):1112-4. PubMed ID: 16681095 [No Abstract] [Full Text] [Related]
26. Drug monitoring of a case of citalopram overdosage. Liotier J; Coudoré F Drug Chem Toxicol; 2011 Oct; 34(4):420-3. PubMed ID: 21846175 [TBL] [Abstract][Full Text] [Related]
27. The Effects of Trimetazidine on QT-interval Prolongation and Cardiac Hypertrophy in Diabetic Rats. Ramezani-Aliakbari F; Badavi M; Dianat M; Mard SA; Ahangarpour A Arq Bras Cardiol; 2019 Feb; 112(2):173-178. PubMed ID: 30570065 [TBL] [Abstract][Full Text] [Related]
28. Torsade de pointes induced by citalopram and amiodarone. Fayssoil A; Issi J; Guerbaa M; Raynaud JC; Heroguelle V Ann Cardiol Angeiol (Paris); 2011 Jun; 60(3):165-8. PubMed ID: 21295285 [TBL] [Abstract][Full Text] [Related]
29. Citalopram, QTc Prolongation, and Torsades de Pointes. Tampi RR; Balderas M; Carter KV; Tampi DJ; Moca M; Knudsen A; May J Psychosomatics; 2015; 56(1):36-43. PubMed ID: 25619672 [TBL] [Abstract][Full Text] [Related]
30. Electrophysiologic effects of nicorandil on the guinea pig long QT1 syndrome model. Yang Z; Shi G; Li C; Wang H; Liu K; Liu Y J Cardiovasc Electrophysiol; 2004 Jul; 15(7):815-20. PubMed ID: 15250869 [TBL] [Abstract][Full Text] [Related]
31. Citalopram (Celexa) and QT interval prolongation. Med Lett Drugs Ther; 2012 Sep; 54(1398):71-2. PubMed ID: 22992488 [No Abstract] [Full Text] [Related]
32. Improvement of repolarization abnormalities by a K+ channel opener in the LQT1 form of congenital long-QT syndrome. Shimizu W; Kurita T; Matsuo K; Suyama K; Aihara N; Kamakura S; Towbin JA; Shimomura K Circulation; 1998 Apr; 97(16):1581-8. PubMed ID: 9593563 [TBL] [Abstract][Full Text] [Related]
33. Is the sarcolemmal or mitochondrial K(ATP) channel activation important in the antiarrhythmic and cardioprotective effects during acute ischemia/reperfusion in the intact anesthetized rabbit model? Das B; Sarkar C Life Sci; 2005 Jul; 77(11):1226-48. PubMed ID: 15964023 [TBL] [Abstract][Full Text] [Related]
34. Clinical Efficacy of Intracoronary Papaverine After Nicorandil Administration for Safe and Optimal Fractional Flow Reserve Measurement. Inoue K; Sonoda S; Naka Y; Okabe H; Setoyama K; Miura T; Anai R; Araki M; Kataoka M Int Heart J; 2021 Sep; 62(5):962-969. PubMed ID: 34544970 [TBL] [Abstract][Full Text] [Related]
35. Cardioprotective effects of nicorandil, a mitochondrial potassium channel opener against doxorubicin-induced cardiotoxicity in rats. Abdel-Raheem IT; Taye A; Abouzied MM Basic Clin Pharmacol Toxicol; 2013 Sep; 113(3):158-66. PubMed ID: 23621757 [TBL] [Abstract][Full Text] [Related]
36. Population pharmacokinetics and pharmacodynamics of escitalopram in overdose and the effect of activated charcoal. van Gorp F; Duffull S; Hackett LP; Isbister GK Br J Clin Pharmacol; 2012 Mar; 73(3):402-10. PubMed ID: 21883384 [TBL] [Abstract][Full Text] [Related]
38. Effect of activated charcoal on citalopram-induced QT prolongation. Greene SC; Brooks DE; Lovecchio F Ann Emerg Med; 2008 Jul; 52(1):86-7; author reply 87-8. PubMed ID: 18565387 [No Abstract] [Full Text] [Related]
39. The Risk of QTc-Interval Prolongation in Breast Cancer Patients Treated with Tamoxifen in Combination with Serotonin Reuptake Inhibitors. Hussaarts KGAM; Berger FA; Binkhorst L; Oomen-de Hoop E; van Leeuwen RWF; van Alphen RJ; Mathijssen-van Stein D; de Groot NMS; Mathijssen RHJ; van Gelder T Pharm Res; 2019 Dec; 37(1):7. PubMed ID: 31845095 [TBL] [Abstract][Full Text] [Related]
40. Effect of estrogen on ventricular repolarization in menopausal patients with syndrome X and effects of nicorandil. Lee TM; Su SF; Lee YT; Tsai CH Am J Cardiol; 1999 Jul; 84(1):65-9. PubMed ID: 10404853 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]